Navigation Links
Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
Date:2/22/2013

THOUSAND OAKS, Calif., Feb. 22, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) notes that an analysis by the Congressional Budget Office released this week shows that, contrary to the implications of past media reports, keeping oral-only drugs in Medicare Part D would actually achieve significant savings over time for both taxpayers and the Medicare program.

As noted by the Government Accountability Office (GAO), it is important that the Centers for Medicare and Medicaid Services (CMS) take the time needed to develop quality metrics and further develop their data systems, both of which are essential to providing quality care for an elderly and chronically ill patient population.

Amgen will continue to advocate for sound federal policies that enhance access to care for these patients.

For more background, please visit Our Perspectives on www.amgen.com.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss , 805-313-6151 (media)
Arvind Sood , 805-447-1060 (investors)

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Selexis Announces Expansion of R&D License Agreement with Amgen
2. Amgen Outlines Long-Term Strategy
3. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
4. Amgen To Webcast 2013 Business Review Meeting On February 7
5. Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
6. Amgen Backs States Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
7. Amgens Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51
8. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
9. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
10. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
11. Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... , ... November 11, 2019 , ... Over 60 schools ... telehealth service in place. The program is designed to provide virtual mental health care ... storm that struck the region in October of 2018 [1]. , “This initiative by ...
(Date:11/11/2019)... , ... November 11, 2019 , ... The Naderi Center ... America health care practice POS, point of sale, website for providing the highest level ... Naderi Center for Cosmetic Surgery Specialists uses advanced financial technology in their daily business ...
(Date:11/11/2019)... ... ... The Advocator Group, LLC, part of Brown & Brown Inc., is honored ... the Boston Globe Magazine. This recognition has been earned for the fourth consecutive year ... , The rankings for the Top 100 Women-Led Businesses in each state are ...
Breaking Medicine Technology:
(Date:11/12/2019)... ... November 12, 2019 , ... ... study. With increasing site activation cycle times, extended contract negotiations and 80 percent ... an area of clinical operations that’s ripe for improvement. Following an overview of ...
(Date:11/11/2019)... IRVINE, Calif. (PRWEB) , ... November 11, 2019 ... ... providers of business support services to dental groups in the United States, today ... serving the community of Lodi, CA. , Patients will enjoy convenient hours, comfortable ...
(Date:11/11/2019)... ... 11, 2019 , ... Dr. John V. Prunskis, co-founder and co-Medical Director of ... Pain Management Best Practices Task Force (Pain Task Force) met last Monday with Joe ... to the HHS Pain Task Force’s final report that was submitted to Congress in ...
(Date:11/9/2019)... YORK (PRWEB) , ... November 09, 2019 , ... On ... the story of a retired and disabled 64-year-old New Yorker who recently faced homelessness. ... moved her into transitional housing until she found a new home in an assisted-living ...
(Date:11/7/2019)... ... 07, 2019 , ... Understanding UDI in EU Device Regulations, An FDAnews Webinar, ... Are EU device and IV diagnostics sales in jeopardy? , It’s not a trick ... ahead, and many device and diagnostics makers simply aren’t prepared. , Not yet anyway. ...
Breaking Medicine News(10 mins):